R. Michael Floyd
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About R. Michael Floyd
Earlier roles on record: COO at Processa Pharmaceuticals, Inc. (PCSA) until August 31, 2023. Processa Pharmaceuticals, Inc. reported in an 8-K filed August 8, 2023 that R. Michael Floyd resigned as Chief Operating Officer, effective August 31, 2023.
“By mutual agreement, Mr. R. Michael Floyd resigned as Chief Operating Officer of the Company, effective August 31, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-10-01–2023-08-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.